Third Wave in Deal with British Institutions | GenomeWeb

NEW YORK, Sept 14 - Third Wave Technologies said Thursday it had reached an agreement to provide Imperial College of Great Britain, Royal Brompton's Hospital, and the UK National Health Service Trust with access to its Invader operating system for SNP detection and gene expression analysis.

Under the terms of the deal, Third Wave of Madison, Wis., will provide the institutions with preferred access to its pharmacogenomic assays as well as offer additional support for their genomics research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.